Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-11 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.130 | ||||||
REV | 356.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
VXRT | Vaxart | 6.02 | 0.10 | 1.69% | 709M |
You can purchase shares of Vaxart (NASDAQ: VXRT) through any online brokerage.
Other companies in Vaxart’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Chinook Therapeutics (NASDAQ:KDNY) and Gritstone Oncology (NASDAQ:GRTS).
The latest price target for Vaxart (NASDAQ: VXRT) was reported by HC Wainwright & Co. on 2020-08-12. The analyst firm set a price target for 17.00 expecting VXRT to rise to within 12 months (a possible 182.39% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Vaxart (NASDAQ: VXRT) is $6.02 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Vaxart.
There is no upcoming split for Vaxart.